Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer (Q34596369)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer |
scientific article |
Statements
1 reference
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer (English)
1 reference
James L Abbruzzese
1 reference
Henry Q Xiong
1 reference
Gauri R Varadhachary
1 reference
Joan C Blais
1 reference
Kenneth R Hess
1 reference
Robert A Wolff
1 reference
1 October 2008
1 reference
Identifiers
1 reference